TY - JOUR T1 - A Survey on the Current Evaluation and Treatment of Gout in Buenos Aires, Argentina JO - Reumatología Clínica (English Edition) T2 - AU - Fara,Nauan AU - Vázquez Mellado,Janitzia AU - Sequeira,Gabriel AU - Kerzberg,Eduardo SN - 21735743 M3 - 10.1016/j.reumae.2012.05.004 DO - 10.1016/j.reumae.2012.05.004 UR - https://www.reumatologiaclinica.org/en-a-survey-on-current-evaluation-articulo-S2173574312001529 AB - ObjectiveTo evaluate the current management of gout in general practitioners and specialists in Buenos Aires city. Material and methodsMultiple choice, anonymous, survey, performed on 33 rheumatologists (REU), 52 Internal Medicine specialists (EMI) and 86 general practitioners (Otros). ResultsGout is a very common or usual disease for 51.5% of REU vs 11.5% EMI and 8.1% Otros. At diagnosis, uric acid crystals are identified by 51.5% REU vs 28.8% EMI and 26.7% Otros and tophi observed by 60.6% REU vs 30.8% EMI and 30.2% Otros. REU and EMI should indicate colchicine for acute gout in 75.8% and 80.8% respectively vs 7.7% of Otros. REU measure patient's height/weight and waist circumference less frequently than EMI (66.7% vs 92.3% and 45.5% vs 75% respectively). ConclusionsREU usually examine patients with gout but in a chronic stage. The identification of crystals in synovial fluid is low. The use of colchicine is still high. REU should improve the evaluation of the metabolic syndrome. ER -